Similar articles for PMID: 29330244

Year	Number of Results
1979	1
1996	1
2000	1
2001	3
2002	1
2003	3
2004	1
2005	2
2006	1
2007	1
2008	1
2009	2
2010	8
2011	4
2012	7
2013	14
2014	10
2015	17
2016	10
2017	14
2018	21
2019	21
2020	24
2021	20
2022	5

1

Primary Care Physicians' Struggle with Current Adult Pneumococcal Vaccine Recommendations.

Hurley LP, Allison MA, Pilishvili T, O'Leary ST, Crane LA, Brtnikova M, Beaty BL, Lindley MC, Bridges CB, Kempe A. Hurley LP, et al. J Am Board Fam Med. 2018 Jan-Feb;31(1):94-104. doi: 10.3122/jabfm.2018.01.170216. J Am Board Fam Med. 2018. PMID: 29330244 Free PMC article.

2

Pneumococcal Vaccination Among Medicare Beneficiaries Occurring After the Advisory Committee on Immunization Practices Recommendation for Routine Use Of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults Aged ≥65 Years.

Black CL, Williams WW, Warnock R, Pilishvili T, Kim D, Kelman JA. Black CL, et al. MMWR Morb Mortal Wkly Rep. 2017 Jul 14;66(27):728-733. doi: 10.15585/mmwr.mm6627a4. MMWR Morb Mortal Wkly Rep. 2017. PMID: 28704347 Free PMC article.

3

Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).

Nuorti JP, Whitney CG; Centers for Disease Control and Prevention (CDC). Nuorti JP, et al. MMWR Recomm Rep. 2010 Dec 10;59(RR-11):1-18. MMWR Recomm Rep. 2010. PMID: 21150868 Free article.

4

Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Tomczyk S, Bennett NM, Stoecker C, Gierke R, Moore MR, Whitney CG, Hadler S, Pilishvili T; Centers for Disease Control and Prevention (CDC). Tomczyk S, et al. MMWR Morb Mortal Wkly Rep. 2014 Sep 19;63(37):822-5. MMWR Morb Mortal Wkly Rep. 2014. PMID: 25233284 Free PMC article.

5

Recent Developments and Future Directions of Pneumococcal Vaccine Recommendations.

Tromp KM, Campbell MW, Vazquez A. Tromp KM, et al. Clin Ther. 2015 May 1;37(5):928-34. doi: 10.1016/j.clinthera.2015.03.025. Epub 2015 Apr 23. Clin Ther. 2015. PMID: 25913921 Review.

6

Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Kobayashi M, Bennett NM, Gierke R, Almendares O, Moore MR, Whitney CG, Pilishvili T. Kobayashi M, et al. MMWR Morb Mortal Wkly Rep. 2015 Sep 4;64(34):944-7. doi: 10.15585/mmwr.mm6434a4. MMWR Morb Mortal Wkly Rep. 2015. PMID: 26334788 Free article.

7

Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2012 Oct 12;61(40):816-9. MMWR Morb Mortal Wkly Rep. 2012. PMID: 23051612 Free article.

8

Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60-64 years of age.

Greenberg RN, Gurtman A, Frenck RW, Strout C, Jansen KU, Trammel J, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B. Greenberg RN, et al. Vaccine. 2014 Apr 25;32(20):2364-74. doi: 10.1016/j.vaccine.2014.02.002. Epub 2014 Mar 5. Vaccine. 2014. PMID: 24606865 Clinical Trial.

9

Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2013 Jun 28;62(25):521-4. MMWR Morb Mortal Wkly Rep. 2013. PMID: 23803961 Free PMC article.

10

Call to action on pneumococcal disease: review of vaccination evidence and outcomes of webcast programs.

Grogg SE, Schultz J. Grogg SE, et al. J Am Osteopath Assoc. 2015 Jun;115(6 Suppl):S6-25. doi: 10.7556/jaoa.2015.071. J Am Osteopath Assoc. 2015. PMID: 26000904 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed